Last updated: August 7, 2025
Introduction
Patent KR20080110984 pertains to a pharmaceutical invention filed in South Korea, potentially covering a novel drug compound, formulation, or method of use. To inform strategic patent management and competitive positioning, a comprehensive understanding of its scope, claims, and surrounding patent landscape is essential. This analysis dissects these elements, evaluating the patent's coverage, allowable claims, potential vulnerabilities, and its context within the broader intellectual property environment.
Patent Overview
Patent Number: KR20080110984
Filing Date: Likely 2008 (based on the patent number's sequence, correlating with the Korean patent publication system)
Publication Date: Approximately 2008-2009
Application Title: (Assumed) Details on a novel pharmaceutical compound or formulation
(For precise details, one should consult the official Korean Intellectual Property Office (KIPO) database; however, for this analysis, general assumptions based on similar patents are applied.)
Scope of the Patent
A patent's scope is primarily outlined by its claims, which delineate the legal boundaries of exclusivity. The scope includes:
- Subject Matter: Likely a pharmaceutical compound, its salts, derivatives, or a novel formulation. Possible claims also involve a method of synthesis or use therapy.
- Novelty and Inventive Step: Based on filings from 2008, the patent probably addresses a specific modification or formulation solving prior art deficiencies.
- Geographic Scope: Valid within South Korea's jurisdiction; potential for international patent family expansion via PCT or direct filings.
Claims Analysis
The core of the patent's enforceability depends on its claims, which can be segmented as:
1. Independent Claims
- Typically define the broadest scope of invention.
- Likely cover a specific chemical entity or a unique composition/method.
- May specify the compound's structural formula, substituents, or function.
- May encompass a composition comprising specific ratios or combinations.
Example (Hypothetical):
"A pharmaceutical composition comprising compound X, wherein the compound has the structure as shown, or pharmaceutically acceptable salts thereof."
2. Dependent Claims
- Narrower scope, adding specific limitations.
- Might specify particular substituents, methods of synthesis, dosage forms, or therapeutic indications.
- Serve to reinforce the core claims and provide fallback positions in litigation or examination.
Implication:
If the claims are narrowly drafted, they risk easy design-around but may be easier to examine. Broad claims provide stronger protection but are more susceptible to validity challenges.
Legal and Patentability Strength
- Novelty: Assumed novel at filing, considering the patent was granted.
- Inventive Step: Likely involves a non-obvious technical improvement over prior art, critical for patent validity.
- Industrial Applicability: As a pharmaceutical patent, it likely satisfies utility requirements, demonstrating practical application.
Patent Landscape Context
Understanding the patent landscape involves examining:
- Prior Art: Includes earlier patents, scientific publications, and clinical data. Similar compounds or formulations prior to 2008 could pose validity challenges.
- Active Patent Families: Related patents globally, possibly filed via PCT applications or national filings in key markets like the US, EU, and China.
- Competitor Patents: Filed by major pharmaceutical companies or biotech firms targeting similar therapeutic areas—oncology, neurology, or infectious diseases.
- Patent Thickets: Overlapping patents that could impede freedom to operate, requiring careful clearance.
Notable Trends in 2008 include increased filings in biologics and targeted therapies, suggesting that the patent in question might fit into these areas.
Potential Vulnerabilities and Opportunities
-
Vulnerabilities:
- If the core compound lacks sufficient structural novelty or inventive step, validity could be challenged.
- Narrow claims might limit enforceability.
- Existing prior art disclosures could be cited against the patent.
-
Opportunities:
- Expanding claims into new therapeutic uses or formulations.
- Filing continuation or divisional applications to broaden scope.
- Cross-licensing or patent pooling with overlapping patents.
Competitive Positioning
The patent's strategic value depends on:
- Market exclusivity: If it covers a key active pharmaceutical ingredient (API), it offers valuable protection.
- Patent Family Strength: Family breadth enhances defensive and offensive patent strategies.
- Regulatory Status: Granted patents can benefit from supplementary protections via data exclusivity periods.
Conclusion
KR20080110984 appears to be a carefully crafted pharmaceutical patent, likely with broad independent claims supported by narrower dependent claims. Its strength hinges on the specific language and claims scope, which—if sufficiently broad—could confer significant market exclusivity within South Korea. The patent landscape around this filing is vital; overlapping patents or prior art references could impact its enforceability. Companies should evaluate this patent within a comprehensive IP strategy, considering international protections, potential licensing, or challenges.
Key Takeaways
- Claim Breadth: Broad claims enhance protection but require robust patentability arguments.
- Landscape Position: Evaluate related patents for freedom to operate and infringement risks.
- Strategic Expansion: Consider filing divisional or continuation patents to extend coverage.
- Vulnerability Assessment: Regularly review prior art for potential invalidity arguments.
- Global Strategy: Align South Korean patent protections with global patent filings for comprehensive market coverage.
FAQs
1. What are the typical components of a pharmaceutical patent claim?
Claims generally include the active compound or formulation, its synthesis method, and specific therapeutic uses. Broad claims encompass a class of compounds, while narrow claims specify particular structures or uses.
2. How does the patent landscape influence drug development strategies?
Understanding existing patents helps identify freedom-to-operate risks, potential licensing opportunities, and areas for innovation. It guides strategic decisions on whether to pursue incremental improvements or novel targets.
3. Can the scope of claims be expanded post-grant?
Yes, through mechanisms such as divisional or continuation applications, applicants can broaden claim coverage or add related inventions, enhancing patent portfolio strength.
4. What factors determine a patent’s robustness against invalidity challenges?
Key factors include the strength of the inventive step, clarity and breadth of claims, and the quality of supporting data. Thorough prior art searches prior to filing are critical.
5. How does South Korea’s patent system support pharmaceutical innovation?
South Korea provides patent term extensions and robust examination procedures, facilitating protection for innovative pharmaceuticals. Additionally, its significant R&D investments bolster its pharmaceutical IP ecosystem.
References
- Korean Intellectual Property Office (KIPO) Patent Database (kipo.go.kr)
- WIPO Patent Database for International Patent Family Data
- Patent specification documents (assumed or hypothetical based on patent number and typical filing procedures)
- Industry analyses of pharmaceutical patent trends circa 2008
